ARVO 2024: Possible link between long COVID, vision changes tops Healio’s written items
As Healio’s coverage of the Association for Research in Vision and Ophthalmology meeting winds down, catch up on this year’s most popular articles.
Hot topics include a possible link between vision changes and a severe form of long COVID and ChatGPT’s underwhelming success rate when attempting to pass an ophthalmology board exam.
Vision changes in patients with long COVID may reflect severe disease phenotype
Persistent vision changes were found to be a symptom of severe forms of long COVID and were associated with worse clinical manifestations, according to a poster presentation. Read more.
ChatGPT would not pass ophthalmology board exam
If ChatGPT were to take an ophthalmology board-style exam, it would not pass, even if given feedback and a second chance, according to a poster presentation. Read more.
Study examines national estimates of new onset vision impairment in older patients
Despite a high prevalence of visual impairment among older patients, some make improvements year-over-year, according to a study. Read more.
Phase 2 nonproliferative diabetic retinopathy trial misses primary endpoint
The phase 2 PAVIA trial investigating Duravyu, previously known as EYP-1901, for the treatment of nonproliferative diabetic retinopathy did not meet its primary endpoint, according to a press release from EyePoint Pharmaceuticals. Read more.
Faricimab achieves inactive disease in veteran population with AMD
Patients with age-related macular degeneration in a veteran population experienced an increase in inactive disease after treatment with faricimab, according to a poster presentation. Read more.